View Single Post
phion
#1
Feb4-13, 04:23 PM
PF Gold
phion's Avatar
P: 55
A Techwise Conversation with Nina Tandon, EE and tissue engineer
BY STEVEN CHERRY // WED, JANUARY 30, 2013

Testing newly developed drugs is utterly necessary, but it’s not without its problems. For one thing, it’s expensive. For another, it’s not very accurate—it usually starts with mice, and they’re not like people in the ways we need them to be. It continues with humans, and often even human subjects are not like the people needing the drug, in the ways we need them to be. And we’re putting those people at risk. And did I mention how expensive it is?
link

iPSCs

Nina Tandon
Phys.Org News Partner Medical research news on Phys.org
Time of arrival at hospital impacts time to treatment and survival of heart attack patients
Informal child care significantly impacts rural economies, study finds
Generation of tanners see spike in deadly melanoma